Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Foreign investors pour Into Indian stock markets despite GDP contraction

researchsnappy by researchsnappy
September 6, 2020
in Investment Research
0
Foreign investors pour Into Indian stock markets despite GDP contraction
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

India’s shrinking economy is not stopping foreign investors from pouring money into the nation’s stocks betting on a recovery.

International buyers plowed a net $6 billion into shares in Asia’s third-largest economy in August, the most since March last year. That’s as all other markets in the region excluding China suffered net withdrawals during the month.

Part of it is a bet that Indian equities will play catch-up after trailing the region’s benchmark so far in 2020: the S&P BSE Sensex has underperformed the MSCI Asia Pacific Index by about 6.5 percentage points. Foreigners were also drawn to share sales by some of India’s marquee financial firms — ICICI Bank Ltd., Axis Bank Ltd. and mortgage lender Housing Development Finance Corp raised a combined ($4.7 billion) last month.

“We place India at the top of the list with China for investment returns over the next 12-24 months,” said Nuno Fernandes, who helps oversee more than $2 billion in emerging-market assets at GW&K Investment Management LLC in New York. “India equities represent one of the fastest growth areas in the world.”

Foreigners have remained net buyers even after data Monday showed India’s economy shrank by a record 23.9% in the June quarter, putting in a net $231 million in the first three days of September. Helping them look past the grim GDP data is the improvement in business activity from July after the lockdown curbs were eased.

“We need to look beyond the near term and consider companies that will benefit from the normalization of economic activity and demand,” said Amit Goel, a fund manager at Fidelity International. Goel, who oversees $1.6 billion in India Focus Fund, said he bought shares of private banks, a large staples company and health-care firms in the past three months.

Still, rapidly rising virus cases have put a dampener on investor confidence. With the number nearing 4 million, India is becoming the world’s new virus epicenter.

“As long as Covid-19 cases continue, localized lockdowns are likely to hinder an economic recovery,” said Kristy Fong, senior investment director for Asian Equities at Aberdeen Standard Investments. Aberdeen has turned “more defensive” as it expects a “patchy rather than a V-shaped recovery,” she said.

For the bulls, there remain plenty of reasons to be optimistic about Indian shares.

“The worst is behind us and we’re steadily heading toward a recovery,” Amit Shah, head of India equity research at BNP Paribas said in a note Thursday, citing improving auto sales, plentiful rains that will improve rural wages and the central bank’s easy monetary policy. BNP expects the Sensex to end the year at 41,500, 8% higher from Friday’s close.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Topics

Previous Post

Consumer Telematics Systems Market Global Demand, Latest Technology and Outlook 2020 to 2025 – The Daily Chronicle

Next Post

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Next Post
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com